Primary Site >> Biliary tract Cancer
Gene >> CD28
| 1. | |||||||||||
| Journal: | Cancer Res. 1996 Sep 15;56(18):4205-12. | ||||||||||
| Title: | MUC1-specific targeting immunotherapy with bispecific antibodies: inhibition of xenografted human bile duct carcinoma growth. | ||||||||||
| Author: | Katayose, Y|Kudo, T|Suzuki, M|Shinoda, M|Saijyo, S|Sakurai, N|Saeki, H|Fukuhara, K|Imai, K|Matsuno, S | ||||||||||
| PMID: | 8797593 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Immunol Immunother. 2001 Dec;50(10):539-48. | ||||||||||
| Title: | Mutated SEA-D227A-conjugated antibodies greatly enhance antitumor activity against MUC1-expressing bile duct carcinoma. | ||||||||||
| Author: | Kodama, H|Suzuki, M|Katayose, Y|Shinoda, M|Sakurai, N|Takemura, S|Yoshida, H|Saeki, H|Ichiyama, M|Tsumoto, K|Asano, R|Kumagai, I|Imai, K|Hinoda, Y|Matsuno, S|Kudo, T | ||||||||||
| PMID: | 11776376 | ||||||||||
| 3. | |||||||||||
| Journal: | Immunol Lett. 2002 Apr 22;81(2):99-106. | ||||||||||
| Title: | Specific and effective targeting cancer immunotherapy with a combination of three bispecific antibodies. | ||||||||||
| Author: | Kodama, Hideaki|Suzuki, Masanori|Katayose, Yu|Shinoda, Masao|Sakurai, Naoki|Takemura, Shin-ichi|Yoshida, Hiroshi|Saeki, Hisaaki|Asano, Ryutaro|Ichiyama, Masahiko|Imai, Kohzoh|Hinoda, Yuji|Matsuno, Seiki|Kudo, Toshio | ||||||||||
| PMID: | 11852114 | ||||||||||
| 4. | |||||||||||
| Journal: | Tumour Biol. 2017 Apr;39(4):1010428317695949. | ||||||||||
| Title: | Mesothelin-targeting chimeric antigen receptor-modified T cells by piggyBac transposon system suppress the growth of bile duct carcinoma. | ||||||||||
| Author: | Xu, Jie-Ying|Ye, Zhen-Long|Jiang, Du-Qing|He, Jiang-Chuan|Ding, Yong-Mei|Li, Lin-Fang|Lv, Sai-Qun|Wang, Ying|Jin, Hua-Jun|Qian, Qi-Jun | ||||||||||
| PMID: | 28381173 | ||||||||||